Psoriasis Research Study for Patients Who are Not Responding to Adalimumab (Humira®)

This research study will examine the safety and effectiveness of a Health Canada approved medication for psoriasis.  Study participants must be at least 18 years of age and be currently receiving treatment with adalimumab (Humira®) or have discontinued treatment with adalimumab (Humira®) within the past 6 months.

The total time commitment for this study is approximately 7 months and will involve up to 9 visits to the study centre.  Compensation may be available for time and travel associated with the study.

The study is being conducted by Dermatologists who specialize in the assessment of psoriasis.

For more information please contact the Dermatology clinic near you or register now.

Learn more about

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more